Global Decentralized Clinical Trials Market
Healthcare Services

Rising telemedicine adoption is accelerating growth in decentralized clinical trials market

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Does The Market Size Of The Decentralized Clinical Trials Market Compare Between 2026 And 2030?

The decentralized clinical trials market has experienced rapid growth in its size over recent years. It is projected to expand from $8.77 billion in 2025 to $10.31 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 17.7%. This historical expansion can be attributed to several factors, including the increasing complexity of clinical trials, the heightened necessity for efficient patient recruitment, the proliferation of digital health technologies, the wider implementation of electronic data capture systems, and an increasing regulatory openness to decentralized models.

The decentralized clinical trials market is projected to experience significant expansion in the coming years. Its valuation is set to reach $19.55 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 17.3%. This anticipated growth during the forecast period is driven by factors such as the increasing adoption of hybrid trial designs, a rising demand for swifter drug development timelines, the expansion of global virtual trials, the growing utilization of AI-driven trial optimization, and an increasing focus on diverse patient participation. Major trends expected within this period include a greater adoption of remote patient monitoring tools, the expanding use of virtual trial platforms, an increase in wearable-based data collection, the rising implementation of real-time trial analytics, and an enhanced focus on patient-centric trial design.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/decentralized-clinical-trials-global-market-report

What Leading Drivers Are Supporting The Decentralized Clinical Trials Market Expansion?

The growing emphasis on telemedicine is projected to stimulate growth in the decentralized clinical trials market moving forward. Telemedicine is defined as the provision of healthcare services remotely via digital communication technologies, enabling medical consultations and monitoring without requiring physical attendance at healthcare facilities. The increasing focus on telemedicine is primarily driven by the need for readily available healthcare delivery in response to global health issues and requirements for social distancing. Decentralized clinical trials utilize telemedicine to remotely engage with and oversee patients, minimizing in-person visits while facilitating real-time data collection, enhanced access, and continuous monitoring. For instance, in September 2024, according to the Australian Bureau of Statistics (ABS), Australia’s national statistical agency, 83.5% of males reported using telehealth services in 2023–24, an increase from 78.6% in 2022–23. Thus, the rising focus on telemedicine is propelling the expansion of the decentralized clinical trials market.

What Segment Categories Shape The Decentralized Clinical Trials Market Segment Landscape?

The decentralized clinical trials market covered in this report is segmented –

1) By Type: Interventional, Observational, Expanded Access

2) By Technology Used: Wearable Devices, Mobile Health Applications, Telemedicine Platforms, Electronic Data Capture Systems

3) By Study Phase: Phase I, Phase II, Phase III, Phase IV

4) By Therapeutic Area: Oncology, Cardiology, Neurology, Infectious Diseases

5) By End-User: Pharmaceutical Companies, Biotechnology Firms, Contract Research Organizations, Regulatory Authorities, Academic And Research Institutions

Subsegments:

1) By Interventional: Randomized Controlled Trials (RCTs), Non-Randomized Trials, Adaptive Clinical Trials, Pragmatic Clinical Trials

2) By Observational: Cohort Studies, Case-Control Studies, Cross-Sectional Studies, Prospective Studies, Retrospective Studies, Longitudinal Studies

3) By Expanded Access: Treatment Investigational New Drug (IND) Applications, Intermediate-Size Patient Population Investigational New Drug (IND) Applications, Single-Patient Investigational New Drug (IND) Applications, Emergency Use Investigational New Drug (IND) Applications

What Emerging Trends Are Seen In The Decentralized Clinical Trials Market?

Leading firms in the decentralized clinical trials sector are concentrating on creating sophisticated tools, specifically all-in-one, no-code clinical trials software, to streamline trial setup and administration, thereby boosting efficiency and patient participation. Such software enables researchers to conceptualize, oversee, and conduct trials without requiring programming knowledge, simultaneously bringing together patient recruitment, data collection, oversight, and analysis within one easy-to-use platform. A notable example is Medable, a US-based clinical technology company, which introduced Medable Studio in August 2024. This all-in-one, no-code software solution aims to simplify and speed up the setup, conversion, verification, and deployment of electronic Clinical Outcome Assessments (eCOA), eConsent, Televisit, and sensors Plus in clinical trials. This platform allows biopharmaceutical firms to develop study designs compliant with protocols in mere hours, a process that previously took months, thereby granting users enhanced control, clarity, and swiftness. It also provides adaptable self-service, full-service, or hybrid models, substantially cutting down study initiation times and expenses. Ultimately, this system seeks to transform trial execution by making the process of building studies quicker, more effective, and less reliant on external professional support.

Who Are The Companies Operating Across The Decentralized Clinical Trials Market Value Chain?

Major companies operating in the decentralized clinical trials market are Walgreens Boots Alliance Inc., Pfizer Inc., Oracle Corporation, Thermo Fisher Scientific Inc., IQVIA Holdings Inc., Labcorp Holdings Inc., ICON Public Limited Company, Dassault Systèmes SE, LEO Pharma A/S, Verily Life Sciences LLC, ProPharma, Signant Health Holding Corp., PCM Trials, Huma Therapeutics Limited, Medable Inc., Science 37 Inc., Obvio Health, EmVenio Research Inc., Grove AI Inc., Phesi Inc.

Get The Full Decentralized Clinical Trials Market Report:

https://www.thebusinessresearchcompany.com/report/decentralized-clinical-trials-global-market-report

Which Region Holds The Highest Market Share In The Decentralized Clinical Trials Market?

North America was the largest region in the decentralized clinical trials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the decentralized clinical trials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Decentralized Clinical Trials Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/decentralized-clinical-trials-global-market-report

Browse Through More Reports Similar to the Global Decentralized Clinical Trials Market 2026, By The Business Research Company

Clinical Trial Supply And Logistics Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-trial-supply-and-logistics-global-market-report

Virtual Clinical Trials Market Report 2026

https://www.thebusinessresearchcompany.com/report/virtual-clinical-trials-global-market-report

Clinical Trial Management System Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-trial-management-system-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Leave a Reply

Your email address will not be published. Required fields are marked *